Risperdal in Children
Risperdal, an antipsychotic prescription medication, is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Although Risperdal was initially designed for elderly patients as a medication to treat dementia and approved in 1993 by the U.S. Food and Drug Administration (FDA), clinical trials suggested that Risperdal could be beneficial to children with bipolar disorder and autism. However, the FDA did not approve Risperdal in children until 2006, and Risperdal has recently been linked to a gynecomastia, or the development of breast tissue in males.
If you or your child have developed gynecomastia while taking the medication, Bernstein Liebhard LLP urges you to seek legal counsel and learn more about the effects of Risperda. You may be entitled to file a claim and seek compensation for your condition.
Complications of Risperdal in Young Boys
Riserpdal, while used in elderly patients, is also taken by children or teens for bipolar disorder, autism and schizophrenia. However, the drug has been clinically proven to increase prolactin levels, a hormone responsible for stimulating breast development in females. As a result, increased prolactin levels in males may cause young boys to develop breast tissue or experience nipple discharge or pain.
Although the most commonly reported complication of Risperdal in kids is that of gynecomastia, the medication may also allegedly cause bone loss, cardiac complications, pancreatitis and other severe side effects.
Symptoms of gynecomastia include swollen breast tissue, pain in the breast, nipple discharge from one or both breasts and tenderness in the breasts. If you or your child developed the condition or experienced other adverse side effects, you may consider seeking legal counsel to learn more about your rights and filing a claim for compensation.
Current Risperdal Litigation
Patients across the U.S. are filing Risperdal lawsuits against the manufacturer, alleging that they suffered adverse and severe side effects while taking the medication. In several claims, young boys allege that they began taking the medication at young ages, before the FDA approved Risperdal for children. According to these claims, inadequately reported or concealed side effects of the drug include pancreatitis, weight gain, hyperprolactinemia, tardive dyskinesia, metabolic syndrome and diabetes, among other risks.
The FDA has issued several warnings related to Risperdal use in children, and Johnson & Johnson recently reached a $2.2 billion settlement with the federal government over its questionable marketing of the medication and other similar products. According to court documents, Johnson & Johnson aggressively promoted Risperdal to children prior to receiving FDA approval for this use, thus needlessly placing the health of young children at risk.
Plaintiffs also allege that the manufacturer knew of the potential dangers of Risperdal but failed to warn the public and medical communities of these risks. Although there are no class action lawsuits as of yet, Johnson & Johnson and Janssen have reportedly begun to settle lawsuits in Pennsylvania alleging that Risperdal use by children caused serious and adverse side effects.
Suffering from Gynecomastia?
If you or a male in your life developed gynecomatia or experienced other adverse health complications while taking Risperdal, you may be entitled to file a claim to recover damages and compensation. The attorneys at Bernstein Liebhard LLP are currently reviewing claims nationwide of injuries pertaining to Risperdal in children and are offering free, no-obligation consultations to those who feel they may have a case. Call us today at (855) 511-1001 to learn more about your legal rights and to schedule your case evaluation.